混合冲击复杂心脏性冲击:频率,预测因素和临床结果
Luca Baldetti1, Guglielmo Gallone2,3, Gaia Filiberti1
1Cardiac Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy (L.B., G.F., A.C., V.R., B.P., L.C., M.G., V.P., S.S., F.C., S.A., A.M.S.).
Circulation. Heart failure
|July 9, 2024
概括
混合性休克 (MS) 在近四分之一的患者中复杂化了心脏性休克 (CS),由分布和炎症变化表明. 这种情况预示着更高的死亡率,强调了在重症监护中需要客观定义的需要.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 血液动力学 血液动力学
背景情况:
- 患有心脏性休克 (CS) 的患者容易发展混合休克 (MS),这是一个分布性-炎症表型的疾病.
- 目前,缺乏对这种临床实体的客观定义.
研究的目的:
- 评估MS复杂化CS的频率,预测因素和预后意义.
- 在CS中使用对MS的新提出的客观定义.
主要方法:
- 分析了200名CS患者的队列.
- 多发性硬化症复杂性硬化症是由初始硬化症诊断后至少12小时出现的特定血液动力学,临床和实验室标准来定义的.
- 预测因素和预后相关性使用统计分析进行了评估.
主要成果:
- 混合性休克 (MS) 并发症心脏性休克 (CS) 在24.5%的患者中发生.
- 降低缩血压,肝损伤和在CS诊断时怀疑感染独立预测MS的发展.
- 多发性硬化症与显著更高的住院死亡率 (53.1%与27.8%) 和更长的住院时间有关.
结论:
- 基于纵向变化的MS复杂化CS的客观定义,确定了大约四分之一的CS患者的情况.
- 预测因素包括诊断时的CS严重程度和炎症标志物.
- 多发性硬化预示着更糟糕的预后,医院死亡率显著增加.
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
766
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
766
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Cardiac Performance
627
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
627
Mechanism of Cardiac Arrhythmias
909
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
909
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
134
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
134


